Vasu Babu Goli

Accomplished Medical Oncologist & BMT Physician with a robust history at prestigious institutions like Tata Memorial Center, specializing in bone marrow transplantation and CAR-T cell therapy. Demonstrates exceptional expertise in treating leukemias and lymphomas, complemented by a commitment to precision oncology. Renowned for innovative treatment approaches, enhancing patient outcomes. Skilled in leadership and cross-disciplinary collaboration.

• Medical Council of India
• Andhra Pradesh Medical Council, 79435
• Maharashtra Medical Council, 2021/01/0079

• ASH Abstract achievement award, 2020
• SOHO - Young Investigator Grant
• 2018
• 2022

• Mycobacterium Tuberculosis Infection at Pacemaker Implantation Site, J Assoc Physicians India, 2017, 65, 2, 88-89
• Musculoskeletal chronic graft versus host disease - A rare complication of allogeneic hematopoietic stem cell transplantation: A case report and review of its literature, South Asian J Cancer, 2017, 6, 4, 150, 10.4103/sajc.sajc_145_17
• Monoclonal gammopathy in chronic lymphocytic leukemia: A case report and review of its literature, Indian J Med Paediatr Oncol, 2018, 39, 257-259
• Loss of Human Epidermal Growth Factor Receptor 2 (HER-2) Expression after Trastuzumab Treatment in Locally Advanced Breast Cancer: A Case Report, Annals of International Medical and Dental Research, 2017, 3, 10.21276/aimdr.2017.3.6.MC1
• Post-transplant Epstein–Barr Virus‑Related Lymphoproliferative Disorder, Indian Journal of Medical and Pediatric Oncology, 2019
• Methotrexate leukoencephalopathy, Cancer Res Stat Treat, 2019, 2, 261-262
• Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial, Lancet Glob Health, 2020, 8, 9, e1213-e1222, 10.1016/S2214-109X(20)30275-8
• Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD, Transpl Infect Dis, 2021, 23, 4, e13576, 10.1111/tid.13576
• Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia, Blood Adv, 2021, 5, 17, 3436-3444, 10.1182/bloodadvances.2020003368
• Subcutaneous Panniculitis-Like T-Cell Lymphoma: Clinical Features and Outcomes from a Single Tertiary Center, Indian J Hematol Blood Transfus, 2021, 37, 4, 697-698, 10.1007/s12288-021-01432-x
• Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India, Cancer Med, 2021, 10, 24, 8777-8788, 10.1002/cam4.4379
• Efficacy and safety of induction weekly paclitaxel and carboplatin in esophageal cancer: A retrospective study, Cancer Research, Statistics, and Treatment, 2022, 5, 2, 247-255, 10.4103/crst.crst_122_22

MD Thesis, Dissertation submitted to the N.B.E Study of serum magnesium levels in Type 2 Diabetic Mellitus DM Thesis, To assess the efficacy and toxicity of paclitaxel and carboplatin in neo-adjuvant setting in esophageal cancer - A retrospective study Awaiting IEC Approval, A phase 1 study of Maintenance therapy with Azacytidine and Pomalidomide for adult patients with AML

• T315I mutation status Post-Hematopoietic stem cell transplantation (HSCT) in CML and Ph positive ALL (Series of five patients and review of literature), HEAMATOCON 2018, Oral Presentation
• Leukemic phase, Lactic acidosis and HLH: A case report and review of literature of lethal triad, HEAMATOCON 2018, Poster Presentation
• Real world Data on safety and efficacy of ABVD in adolescent and young adults, Society of Haematologic Oncology Meeting, 09/11/19 - 09/14/19, Poster Presentation
• Case series of Fatal Geotrichum Clavatum Blood Stream Infection in Stem Cell Transplant Recipients, Asia-Pacific Blood and Bone Marrow Transplantation group (APBMT 2020), 10/11/20, Poster Presentation
• Treatment patterns and outcomes in Acute promyelocytic leukemia - Real world data, European Haematologic Association-2021, 06/2021, Poster Presentation
• Bortezomib and Rituximab in de-novo adolescent/adult CD20-positive, Ph-negative pre-B-cell Acute Lymphoblastic Leukemia - 3 Year Updated results, Society of Haematologic Oncology Meeting, 09/11/22 - 09/14/22, Poster Presentation

• Citizenship: Indian
• Date of Birth: 08/08/90
• Gender: Male
• Marital Status: Married

• ASH Abstract Acheivement Award